Skip to content
2000
Volume 9, Issue 5
  • ISSN: 1573-398X
  • E-ISSN: 1875-6387

Abstract

The nitrogen-containing compound, colchicine, has been used medicinally for millennia. It was first isolated from the plant Colchicum autumnale, by the French chemists P.S. Pelletier and J. Caventon. Today, colchicine is primarily used for the treatment of gout and auto-inflammatory diseases, such as familial Mediterranean fever (FMF), but it has been also investigated for its therapeutic utility in a number of respiratory diseases such as asthma, chonic obstructive pulmonary disease and idiopathic pulmonary fibrosis. While colchicine has shown some promise as an adjuvant to corticosteroid treatment, the benefit of the drug remains to be elucidated. The lack of serious adverse effects of oral colchicine at therapeutic levels should ease the design of more specific trials.

Loading

Article metrics loading...

/content/journals/crmr/10.2174/1573398X10666140526235154
2013-10-01
2025-09-06
Loading full text...

Full text loading...

/content/journals/crmr/10.2174/1573398X10666140526235154
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test